Abstract Purpose of Review This review delves into the complex interplay between obesity-
induced gut microbiota dysbiosis and the progression of type 2 diabetes mellitus (T2DM) …

Metformin is commonly used, but approximately 20% of patients experience gastrointestinal
intolerance, leading to medication discontinuation for unclear reasons and a lack of effective …

Numerous biological environments have been characterized with the advent of
metagenomic sequencing using next generation sequencing which lays out the relative …

Introduction There has been increasing evidence that the gut microbiota is closely related to
type 2 diabetes (T2D). Metformin (Met) is often used in combination with saxagliptin (Sax) …

Background The influence of the microbiota on hypoglycemic agents is becoming more
apparent. The effects of metformin, a primary anti-diabetes drug, on gut microbiota are still …

Objectives This study aimed to determine whether type 2 diabetes (T2D) is an independent
risk factor for sleep disorders in the elderly and explore the possible intestinal flora factors of …

The gut microbiome is a dynamic microecosystem within us that actively influences health
beyond digestion. It impacts energy regulation, the immune response, and even drug …

Oxidative stress and dyslipidemia are common concerns in patients undergoing peritoneal
dialysis (PD) and are associated with adverse clinical outcomes. However, the interplay …

Introducción: En todo el mundo, se observa un aumento constante en la frecuencia de la
Diabetes mellitus tipo 2 (DM2), lo que hace necesario tomar medidas preventivas. Objetivo …

Analysis of the clinical effect size after glucagon-like peptide-1 receptor agonist therapy on the
functional activity of the intestinal microbiota, morpho-metabolic indicators and the level of …